Leap Therapeutics's total assets for Q2 2025 were $20.04M, a decrease of -42.54% from the previous quarter. LPTX total liabilities were $14.32M for the fiscal quarter, a 2.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.